University of Perugia
Also known as: ASL Terni 4, Narni | ASL Terni 4, Narni (TR) - Italy | Azienda Ospedaliera di Perugia | Azienda Ospedaliera Santa Maria, Terni, Italy | Department of Internal Medicine and Public Health, University of Perugia | Department of Internal Medicine - University of Perugia | Ester Illiano, MD | Hematology Section, University of Perugia | Infectious Diseases Clinical, University Hospital of Perugia, Perugia, Italy | Institute of Virology - University of Perugia | Oncologia Medica Ospedale di Perugia | Ospedale Silvestrini Divisione di Neurologia 06156 Loc S Andrea delle Fratte Perugia | Ospedale Silvestrini - Perugia | Ospedale Silvestrini, Perugia | University Of Perugia | University of Perugia, Faculty of Medicine, Department of Internal Medicine | University of Perugia, Italy | University of Perugia, Perugia, Italy
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1994Last known activity
Jun 1, 2024
Timeline
1300s
- Jan 1, 1308
University of Perugia— Founded
Drugs by trial phase (70 distinct, 45 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Arterial Occlusive Diseases
- Atherosclerosis
- Atrial Fibrillation
- Atrophy
- Blood Platelet Disorders
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cerebral Hemorrhage
- Colorectal Neoplasms
- Communicable Diseases
- Cross Infection
- Cystitis, Interstitial
- Digestive System Neoplasms
- Embolism
- Endocrine Gland Neoplasms
- Gastrointestinal Neoplasms
- Hemorrhage
- Hypercholesterolemia
- Hypertension
- Infections
- Inflammation
- Influenza, Human
- Intermittent Claudication
- Intracranial Hemorrhages
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lung Neoplasms
- Metabolic Syndrome
- Motor Neuron Disease
- Multiple Endocrine Neoplasia
- Multiple Myeloma
- Multiple Sclerosis
- Multiple System Atrophy
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neuroendocrine Tumors
- Pain
- Pancreatic Neoplasms
- Parkinson Disease
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Embolism
- Respiratory Tract Neoplasms
- Sclerosis
- Shy-Drager Syndrome
- Stroke
- Syndrome
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Thymus Neoplasms
- Urinary Bladder Neoplasms
- Urinary Bladder, Overactive
- Urinary Tract Infections
- Venous Thromboembolism
- Venous Thrombosis
- Ventricular Dysfunction
- Vomiting
Recent trials (50)
- NCT06398145Lead sponsorPhase 2Jun 1, 2024
- NCT06398145Sponsor investigatorPhase 2Jun 1, 2024
- NCT05343611CollaboratorN/AMay 1, 2022
- NCT04853836Reponsible party - principal investigatorPhase 4Nov 15, 2020
- NCT04853836Lead sponsorPhase 4Nov 15, 2020
- NCT04375202Lead sponsorPhase 2Apr 18, 2020
- NCT04375202Reponsible party - principal investigatorPhase 2Apr 18, 2020
- NCT04801563Reponsible party - principal investigatorN/ASep 20, 2019
- NCT04801563Lead sponsorN/ASep 20, 2019
- NCT04801563Overall official - principal investigatorN/ASep 20, 2019
- NCT03996772CollaboratorPhase 3Jun 3, 2019
- NCT03766321CollaboratorN/AFeb 28, 2019
- NCT04386499Overall official - principal investigatorN/AJan 10, 2019
- NCT04386499Reponsible party - principal investigatorN/AJan 10, 2019
- NCT04386499Lead sponsorN/AJan 10, 2019
Details
- Founded
- Perugia, IT Jan 1, 1308
- Last known activity
- Jun 1, 2024